Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, October 2 2014 12:29pm ET - U.S. Markets close in 3 hours and 31 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Major News
Latest News
Thursday, Oct 2, 2014
·Eli Lilly stops development of lupus drug; XTL shares soar
Reuters - 1 hour, 3 minutes ago
·Novartis (NVS) Presents Data on Zykadia and Afinitor
Zacks.com - 1 hour, 4 minutes ago
·Why Ariad Pharmaceuticals (ARIA) Stock Is Spiking Today
at TheStreet.com - 1 hour, 6 minutes ago
·Early Glance: Pharmaceuticals companies
AP - 1 hour, 45 minutes ago
·EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources
Reuters - 2 hours, 46 minutes ago
·[$$] Lilly to Stop Development of Lupus Treatment
at The Wall Street Journal Online - Thu 9:22 am ET
·Eli Lilly to drop development of lupus drug
Reuters - Thu 8:57 am ET
·Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
- Thu 8:55 am ET
·Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies
PR Newswire - Thu 8:30 am ET
·How Will Eli Lilly (LLY) Stock Be Affected by This Coverage Initiation?
at TheStreet.com - Thu 8:10 am ET
·Ariad Pharma's lung cancer drug gets breakthrough therapy status
Reuters - Thu 7:53 am ET
·Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg
PR Newswire - Thu 7:50 am ET
·What Can the McLaren Racing Team Teach the Rest of Us?
at BusinessWeek - Thu 6:00 am ET
·Innovus Pharma Announces Podium Presentation at the World Meeting of Sexual Medicine, Discussing the Clinical Efficacy of Zestra(R) in Cancer Patients
GlobeNewswire - Thu 6:00 am ET
·NTRR: Contain A Grow Begins Manufacturing First Self-Contained Indoor Growing Unit
Business Wire - Thu 5:00 am ET
·[$$] Bayer Sells $7 Billion Bond
at The Wall Street Journal Online - Thu 3:20 am ET
Wednesday, Oct 1, 2014
·Final Glance: Pharmaceuticals companies
AP - Wed 6:20 pm ET
·Esperion jumps on high-cholesterol drug data
AP - Wed 5:47 pm ET
·The Short-Seller Who Started a Biotech Firm Gets Ousted by His Board
at BusinessWeek - Wed 4:59 pm ET
·Esperion drug succeeds in lowering LDL cholesterol -study
Reuters - Wed 4:05 pm ET
More Latest News...
Sponsor Results
Still Sad?
You May Be Eligible for a Research Study. Contact Us. No Charge.
neuroscience-inc.com/adult-depress
Global Regulatory
Dow Corning Global Expertise Helps You Stay Ahead of Best Practices.
www.dowcorning.com/regulations
Pharma Sample Fulfillment
Full Service Pharmaceutical Sample Fulfillment & Distribution
www.howellmarketingservices.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?